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DURING ROUTINE FLEXIBLE CYSTOSCOPY LISTS
W. Elbaroni*, B.M.K. Thomas. Causeway Hospital, UK
Aim: Amount of ﬂuid needed for ﬂexible cystoscopy is minimal.The
remaining ﬂuid in the bag would be handled differently in different cen-
tres.Our aim was to measure the amount of ﬂuid discarded at Flexible
cystoscopy and calculate the costs involved.
Methods: 132 patients attended forﬂexible cystoscopy between February&
April 2014were included.After every procedure, theﬂuid left over in the bag
was measured.The average ﬂuid wastage per patient was calculated.The
costs for each of the following commonly availableﬂuid bagswere analysed.
Results: It was noted that for 132 patients, the amount of ﬂuid discarded
was 112,131ml and the amount of ﬂuid used was only 19,869 ml.The
average ﬂuid wasted per patient was 849.5 mls.When this was calculated
in retrospect for the year 2013, for 1737cases of ﬂexible cystoscopy,it was
found that about 1,475,581.5ml (ie about 1500 litres / 325 gallons)of ﬂuid
was discarded.
Conclusion: 1. In time of economical difﬁculties there is an obligation to
save money when safe and possible. 2. In our study we studied this and
projected our costs and savings over a year. 3. We identiﬁed by changing
we would have saved £1,607.6 - £3,844.56 amount of money on Flexible
Cystoscopy per year.0525: TRANSPERITONEAL LAPAROSCOPIC NEPHRECTOMY WITH
INTACT SPECIMEN EXTRACTION VIA PFANNENSTIEL NEPHRECTOMY
(PFN) VERSUS EXTENDED PORT SITE EXTRACTION (EPS):
PRELIMINARY EXPERIENCE IN AN UNSELECTED POPULATION
M. Alsawi*, T. Amer, R. Hutton, R. Hasan, D. Biju, R. Clark, B. Little. Ayr
Urology Department, UK
Aim: To conﬁrm the hypothesis that intact renal specimen extraction via a
Pfannenstiel incision for laparoscopic nephrectomy/nephroureterectomy
versus an expanded port site incision causes less pain and therefore re-
duces inpatient stay.
Methods: The laparoscopic approach for nephrectomy/nephrectour-
eterctomy has gained acceptance as the standard treatment for most T1/T2
tumours [1,2]. In the UK most extraction is performed intact but there is a
lack of consensus on optimal extraction site [1]. Tisdale and colleagues [1]
in their case series of 150 which tested this hypothesis found patients
having LRN had a shorter hospital stay (2.84 versus 3.37 days, P <0.05) and
required signiﬁcantly less morphine (23.7 versus 47.3 mg, P <0.006).
Results: There were no demographic differences between the groups. IV
morphine consumption (P¼0.88), paracetamol consumption (P¼0.41) and
duration of inpatient stay (P¼0.43) was shorter for PFN patients versus EPS
patients. These ﬁgures were not signiﬁcant.
Conclusion: This study has demonstrated that the use of Pfanenstiel
extraction sites may have a role to play in intact specimen extraction
during laparoscopic nephrectomy. These authors believe that further work
in the shape of a randomised study is indicated to corroborate or refute
previous assertions in the literature that the beneﬁts of the Pfanenstiel
extraction site extend beyond the cosmetic.
0545: THE EVALUATION OF ROUTINE HISTOLOGICAL SPECIMEN
ANALYSIS FOR ADULT CIRCUMCISIONS IN A HIGH OUTPUT UROLOGY
DEPARTMENT
S. Trecarten*, G. Mann, G. Hulman. University of Nottingham, UK
Aim: Our study aims were to determine: (i) the necessity of routine his-
tological analysis by comparing histological results and clinical suspicion
of pathology for adult circumcision samples, and (ii) rates of undiagnosed
cancer.
Methods: Adult circumcision samples (N¼100) performed at Nottingham
City Hospital from 17/09/2013 to 17/09/2013 were analysed retrospec-
tively. The surgical indication and histological result for each sample were
documented. Subsequently, the clinical prediction and the pathological
result were compared.Results: CLINICAL INDICATION: When cancer was not suspected (N¼94),
themost common indication for surgery was phimosis (N¼80). Cancer was
suspected in 6 patients.
HISTOPATHOLOGICAL RESULTS: For non-cancerous histology (N¼98),
Balanitis Xerotica Obliterans (N¼58) was the most frequent result and
therewere no unpredicted cases of cancer. Of patients suspected for cancer
(N¼6), two cases were conﬁrmed. Overall, the clinical prediction matched
the pathological results in 84% of patients.
Conclusion: When cancer was not suspected (N¼94), the histology result
played little role in further management, and there were no unpredicted
cancers. When cancer was suspected (N¼6), 4 cases were deemed non-
cancerous after histology. Therefore, when cancer is not suspected, it is
recommended that circumcision samples are not routinely analysed. When
cancer is suspected, however, routine histological analysis remains integral.
0619: RECURRENCE-FREE SURVIVAL IN PATIENTS ON STATINS WITH
HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
FOLLOWING INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG)
M. Hillen*, J. Blackmur, P. Jones, G. Nabi. NHS Tayside, UK
Aim: Controversy exists regarding the impact of statins on the clinical
effectiveness of BCG and we aimed to assess the impact of statin use on
outcomes of patients with NMIBC following intravesical BCG therapy.
Methods: All patients who received intravesical BCG therapy for NMIBC
between December 2001 and April 2010 were included in the study. 97
patients were retrospectively analysed. Patient demographics, bladder
cancer pathology, BCG treatment regime, cystoscopic follow-up results,
recurrence bladder cancer pathology and medications were recorded.
Differences between patient characteristics were analysed using stu-
dent t-test. Recurrence-free survival was analysed by Kaplan-Meier
method.
Results: 30 patients (31%) were on a statin at time of ﬁrst intravesical BCG.
There was no signiﬁcant difference in demographic characteristics be-
tween the group on a statin at time of initial intravesical BCG and those not
on a statin (mean p value¼0.41).
There was no signiﬁcant difference in recurrence-free survival between
groups (not on statin mean 75.3 months, on statin 50.2 months; log rank
p¼0.26).
Conclusion: This single centre retrospective study showed that statins
have no impact on bladder cancer recurrence-free or overall survival
following intravesical BCG therapy for NMIBC. Based on these results pa-
tients should continue taking statins whilst receiving BCG therapy.
0648: TRANSPERITONEAL LAPAROSCOPIC NEPHRECTOMY WITH
INTACT SPECIMEN EXTRACTION VIA PFANNENSTIEL NEPHRECTOMY
(PFN) VERSUS EXTENDED PORT SITE EXTRACTION (EPS):
PRELIMINARY EXPERIENCE IN AN UNSELECTED POPULATION
M. Alsawi*, T. Amer, R. Hutton, D. Biju, R. Clarke, B. Little. University
Hospital Ayr, UK
Aim: In the UK there is a lack of consensus on optimal extraction site
following laparoscopic nephrectomy (LPN)/ nephroureterectomy (LPNU).
Multiple studies have suggested reduced analgesia requirements and
shorter hospital stay following intact specimen extraction via Pfanenstiel
incision. We aimed to conﬁrm the feasibility of this compared to the
conventional multiport approach.
Methods: Patients who underwent PFN or EPS extraction for LPN or LPNU
were assessed. Outcome measures were duration of inpatient stay and
total Morphine and Paracetamol consumption
Results: Seven PFN patients and ﬁve EPS patients were analysed. There
was no statistically signiﬁcant difference between study populations with
regards to age. Although the Pfanenstiel group consumed less Paracetamol
this was not statistically signiﬁcant (3.9g +/- 2.2 versus 5.5g +/- 3.9). There
was no statistically signiﬁcant difference in equivalent morphine con-
sumption between the study groups (27.3 +/-13.3 EPS versus 25.4 +/- 29.6
mg).Whilst the mean duration of inpatient stay was less for the Pfanenstiel
group this was not statistically signiﬁcant.
Conclusion: Non-inferiority of PFN was demonstrated in terms of anal-
gesia requirements and duration of inpatient stay. The study however was
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corroborate the beneﬁts of PFN.
0667: HEXAMINOLEVULINATE FLUORESCENCE CYSTOSCOPY: AN AID TO
DIAGNOSIS
S.J. Khan*, B.D. Sarmah. Heart of England NHS foundation Trust, UK
Aim: The aim of this study was to evaluate if Hexaminolevulinate (Hexvix)
ﬂuorescence cystoscopy improved bladder tumour identiﬁcation and man-
agement andwhether repeated episodes ofHexvix incurred further beneﬁts.
Methods: All patients undergoing Hexvix cystoscopy at a District General
Hospital between October 2008 and October 2014 were incorporated. Data
collected and analysed included reason for Hexvix, repeats of Hexvix,
ﬁndings at white-light and Hexvix cystoscopies, complications, histology
and outcomes.
Results: Sixty cases of Hexvix cystoscopies were performed on forty-nine
patients. Nine had repeats and two had a further third episode. No
complications were reported. Reasons for Hexvix included thirty-eight
(63%) for surveillance/abnormal ﬂexible cystoscopy, ten (16.7%) post-BCG
treatment and ten (16.7%) persistently abnormal urine cytology. Twenty-
two (36.7%) conﬁrmed bladder carcinoma. Twenty-two cases docu-
mented white-light and Hexvix ﬁndings. Twelve described no abnor-
malities with white-light which ﬂuoresced using Hexvix. Of these, ﬁve
conﬁrmed malignancy. Three of nine patients conﬁrmed bladder malig-
nancies after the initial Hexvix. Subsequent repeats detected no
abnormalities.
Conclusion: Hexvix improved the detection of bladder tumours, particu-
larly in CIS/pT1G3 tumours. It highlighted areas of malignancies not
visualised by white-light cystoscopy. No additional beneﬁts were seen
from repeating Hexvix cystoscopies.
0680: META-ANALYSIS OF HOLMIUM LASER ENUCLEATION VERSUS
TRANSURETHRAL RESECTION OF PROSTATE FOR PATIENTS WITH
BENIGN PROSTATIC OBSTRUCTION
O. Naser 1,*, A. Negida 2, E. Kasem 2, A. Mokhtar 3, A. Menshawy 4, T.
Badawy 5, A.S. Turky 3, A. Tammam6, A. El-Sawaf 3, B. Gana 1. 1West
Wales General Hospital, UK; 2 Zagazig University, Egypt; 3Menouﬁa
University, Egypt; 4Azhar University, Egypt; 5Alexandria University, Egypt;
6Cairo University, Egypt
Aim: This meta-analysis aims at comparing Holmium laser enucleation
(HoLEP) versus transurethral resection of prostate (TURP) for patients with
benign prostatic obstruction.
Methods: PubMed was searched for RCTs comparing HoLEP versus TURP
using relevant search terms. Data were extracted from eligible studies
and were analyzed using RevMan 5.3 for windows. In case of multiple
reports for the same patients, we analyzed data from the most recent
dataset.
Results: Nine RCTs (871 patients) were included in the ﬁnal analysis.
Follow up ranged from 6 to 92 months. For perioperative outcomes, he-
moglobin loss (SMD¼-0.41, 95% CI¼[-0.60, -0.22]) and blood transfusion
(RR¼0.17, 95% CI¼[0.05, 0.65]) were less in HoLEP than TURP. For post-
operative outcomes, maximum ﬂow rate (SMD¼0.15, 95% CI¼[0.00, 0.29])
and post-void residual volume (SMD¼-0.27, 95% CI¼[-0.46, -0.08]) were
better in HoLEP than TURP. There was no difference in terms of IPSS
(SMD¼-0.01, 95% CI¼[-0.20, 0.19]), AUA symptom score (SMD¼-0.16, 95%
CI¼[-0.35, 0.02]) or QoL (SMD¼0.14, 95% CI¼[-0.06, 0.33]). The overall
relative risk of urethral strictures, incontinence and recatheterization did
not favor either of the two modalities.
Conclusion: HoLEP achieved better changes in Qmax and PVR than TURP.
Hemoglobin loss and perioperative blood transfusion were less in HoLEP
than TURP.
0757: A SERVICE IMPROVEMENT PROJECT FOR EMERGENCY
UROLOGICAL ADMISSIONS
T. Tharakan*, C. Wou, A. Phaily, W. Dunsmuir. Ashford and St Peter's
Hospital NHS Foundation Trust, UKAim: IncreasingA&Eattendances have resulted inmore emergency urology
referrals and subsequent admissions. At our Trust, the surgical senior house
ofﬁcer (SHO) is the gatekeeper for patients with possible urological prob-
lems. Our Trust has moved to a consultant-led service with loss of registrar
cover out-of-hours. A previous Trust audit concluded 29% of all emergency
urological admissions were inappropriate. The registrar timetable was
therefore reconﬁgured to extend their hours from 8pm to 10pm to support
the SHO. This re-audit reviewed admissions after these changes.
Methods: We retrospectively reviewed the notes of 77 patients who were
admitted under the urology team during one month and compared results
to the previous audit.
Results: Total preventable admissions dropped by 11%. Half of these ad-
missions could be managed at home. 72% of inappropriate admission were
admitted out-of-hours. Collectively, these patients stayed in hospital for a
total of 46 days. The total cost for these days is estimated to be over £15,000.
Conclusion: Improvements in registrar timetabling resulted in a 11%
decrease in inappropriate urological admissions, highlighting the impor-
tance of senior support and potential ﬁnancial savings. Further investiga-
tion into the causes of inappropriate admissions is required e.g. depth of
urological knowledge of admitting SHOs.0758: TIMING OF SECOND RESECTION IN HIGH-GRADE NON-MUSCLE-
INVASIVE BLADDER CANCER: DOES DELAY ADVERSELY AFFECT
OUTCOME?
J. Fitzpatrick, D.R. Biju*, T. Amer, R. Hutton, B. Nair. University Hospital Ayr,
UK
Aim: In non-muscle-invasive bladder cancer (NMIBC), there is a risk that
residual tumour may be present after initial resection and that the tumour
is under-staged. There is still debate regarding the optimum timing of
second resection although current guidelines advocate 2-6 weeks. The aim
was to determine whether delay to second resection adversely affects
disease outcomes in NMIBC.
Methods: This was a retrospective analysis of 56 patients with high-grade
(G3) NMIBC from 2005-2010 who underwent repeat resection following
initial TURBT. Data was collected from online databases.
Results: The majority of patients (61%; 34/56) had T1 disease. Out of 56
patients, 50% (28/56) had evidence of residual tumour on repeat resection;
14% (8/56) had been under-staged and 50% (4/8) of these had muscle-
invasive disease which altered treatment. During follow-up, 61% (34/56)
developed recurrence and 25% (14/56) disease progression. Time to second
resectionwas <6 weeks in 30% (17/56) and >6 weeks in 70% (39/56). There
was no signiﬁcant difference in recurrence (76%:54%, p¼0.11) or progres-
sion (35%:21%, p¼0.24) between these two groups.
Conclusion: We ﬁnd no signiﬁcant difference on adverse outcomes when
repeat resection is delayed beyond 6 weeks. Further research is required to
determine the optimum timing for repeat resection.0783: ASSESSMENT OF CLINICAL OUTCOMES OF ORTHOTOPIC NEO-
BLADDER RECONSTRUCTION AFTER RADICAL CYSTECTOMY
A. Anwar*, G.M. Nandwani, R. Singh, R. Chahal, S. Addla. Bradford Royal
Inﬁrmary, UK
Aim: In reconstructive urology orthotopic neobladder is the diversion of
choice. It does not compromise oncological outcome, yields excellent
functional results and cost effective compare to incontinent diversions.
Methods: 128 patients underwent radical cystectomy April 2009 till
October 2014. 109 ileal conduit and 19 had orthotopic neobladder recon-
struction(ONB). Data collected from hospital notes, electronic records.
Patients evaluation on functional outcomes (incontinence, infection, uri-
nary retention, self catheterisation, oncological outcomes (cancer free
survival(CSS), overall survival(OSS), cancer recurrence, pathological stag-
ing) and surgical complications (Clavien-Dindo).
Results: Total n¼19 ONB reconstruction (male¼16, female¼3), age 67 ± 21
years, 67%(n¼12) ASA-1, 37%(n¼7), duration of surgery 370 ± 110 minutes,
blood loss 700 ± 500 mls, Mortality(n¼1) secondary to chest infection. CSS
100%(n¼18) and OSS 94.7% at a median follow-up of 36 ± 14 months. Local
